SCHEMBL19709635

SCHEMBL19709635

Bc1cc2nc(C(C#N)C(=O)NCC(=O)O)sc2cc1F

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 20/20 0.48
▸ LIPC P11150 14/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20972622 0.87 LIPG (0.48) LIPGLIPC
SCHEMBL19709505 0.78 LIPC (0.56) LIPGLIPC
SCHEMBL20972710 0.74 LIPG (0.44) LIPGLIPC
SCHEMBL20972752 0.73 LIPG (0.65) LIPGLIPC
SCHEMBL19709639 0.73 LIPG (0.65) LIPGLIPC
SCHEMBL20972617 0.72 LIPG (0.75) LIPGLIPC
SCHEMBL19709499 0.71 LIPC (0.42) LIPGLIPC
SCHEMBL19709492 0.71 LIPC (0.42) LIPGLIPC
SCHEMBL20999021 0.68 LIPG (0.70) LIPGLIPC
SCHEMBL20972736 0.68 LIPC (0.80) LIPGLIPC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017214005-A1 2-(BENZOTHIAZOL-2-YL)-2-CYANO-ACETAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIAL LIPASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2017-12-14 — — WO disclosed
Send feedback